1. Say on Pay

    0 Comments Leave a Comment

    1-4 of 4
    1. Mentioned In 4 Articles

    2. Investors in AbbVie, Lilly, Amgen and More Set to Vote on Executive Pay, drug pricing

      Investors in AbbVie, Lilly, Amgen and More Set to Vote on Executive Pay, drug pricing
      Several drugmakers resisted shareholder resolutions into the relationship between executive pay and drug prices. (Pixabay) Despite resistance from top pharma companies, shareholders are set to vote this spring on resolutions seeking more information about potential links between executive pay and rising drug prices...
      Read Full Article
    3. 1-4 of 4
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes about Say on Pay

    1. With respect to say on pay, we found differences in shareholder support at companies with favorable voting below 50%, specifically that retail shareholders supported say on pay at higher rates than institutional shareholders.
      In Directors Elected with Increased Level of Shareholder Support
    2. Our research found that a FAILED Say on Pay vote is not a reliable indicator of future stock price performance.
      In Executive Compensation Policies From Proxy Advisors May Not Improve Total Shareholder Returns at Public Companies
    3. Shareholders continued to support say on pay voting at high levels
      In 2015 Proxy Season Characterized by an Uptick in Many Forms of Shareholder Activism